Reader sentiment, not investment advice. One vote per visitor; click again to change it.
PLSE last changed hands at $50.50 (up 5.43%). At $3.60B, Pulse Biosciences is ranked #2357 by size among the 3132 stocks on BeStock.
Over a full year the shares have ranged across $12.56 to $58.90, which puts the current price roughly 82% of the way up that band.
6 analysts follow the stock and the average call is "buy". The mean target, $54.00, sits 6.9% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 2 factors below, ranked against the 3132 U.S. stocks BeStock covers.
Trading closer to its 52-week high than most peers scores higher.
6 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
PLSE is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $54.00, 6.9% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $46.69, so shares trade 8.2% above that estimate.
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 5, 2026 10:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,132 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$50.50 is the latest print for PLSE, a move of +5.43% against yesterday's close of $47.90. Today's low and high so far: $47.47 and $50.99.
Equity value comes to $3.60B at the current price. By that measure it is number 2357 of the 3132 names in our coverage.
The year's floor is $12.56 and the ceiling $58.90. Shares are 14.3% away from that ceiling.
Our data shows no dividend paid by Pulse Biosciences over the trailing twelve months.
Of 6 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $54.00, with the most cautious at $35.00 and the most optimistic at $73.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on PLSE.